share_log

Clarus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner THOMAS MCNERNEY & PARTNERS LP

Clarus Therapeutics | 4/A:持股变动声明(修正)-股东 THOMAS MCNERNEY & PARTNERS LP

2022/04/25 17:17
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息